Abbott is doubling down on the structural heart space, as it aims to gain ground in valve replacements following the recent ...

Colchicine, derived from the autumn crocus plant used medicinally for thousands of years in Egypt, is an anti-inflammatory ...

JenaValve Technology doses first patient in ARTIST study for evaluating Trilogy system in patients with aortic regurgitation: Irvine, California Thursday, July 17, 2025, 16:30 Hrs ...

Background Current guidelines for aortic valve replacement (AVR) lack consensus on prosthesis selection in middle-aged patients. This study aimed to provide a comprehensive comparison of long-term ...

A patient forum identified the desire for better, earlier education as well as the toll on independence TR takes as it ...

JANESVILLE -- Mercyhealth has successfully performed its 300th TAVR procedure, the health system said in a release. A transcatheter aortic valve replacement procedure (TAVR) is a minimally invasive ...

Caranx Medical receives US FDA clearance for an AI-driven intra-operative software, Tavipilot Soft for US commercialization: Nice, France Thursday, July 17, 2025, 17:00 Hrs [IST] ...

JenaValve announced today that it began patient enrollment in the ARTIST study evaluating its Trilogy heart valve system.

Transcatheter aortic valve implantation (TAVI) is now an established treatment option for elderly patients with severe ...

For the first time in India, doctors at Rajasthan Hospital, Jaipur have successfully replaced a heart valve through the ...

JenaValve Technology, Inc., developer and manufacturer of the Trilogy™ Transcatheter Heart Valve (THV) System, today announced that patient enrollment has begun in the ARTIST study, an RCT evaluating ...

The global transcatheter heart valve replacement (TAVR) market is estimated to be valued at USD 8.18 billion in 2025 and is projected to reach USD 32.82 billion by 2035, registering a compound annual ...